You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

PHYTONADIONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Phytonadione

A generic version of PHYTONADIONE was approved as phytonadione by AMNEAL PHARMS CO on May 11th, 2018.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PHYTONADIONE?
  • What are the global sales for PHYTONADIONE?
  • What is Average Wholesale Price for PHYTONADIONE?
Summary for PHYTONADIONE
Drug patent expirations by year for PHYTONADIONE
Drug Prices for PHYTONADIONE

See drug prices for PHYTONADIONE

Recent Clinical Trials for PHYTONADIONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of SydneyPhase 3
Australasian Kidney Trials NetworkPhase 3
Waitemata District Health BoardPhase 3

See all PHYTONADIONE clinical trials

Pharmacology for PHYTONADIONE

US Patents and Regulatory Information for PHYTONADIONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cipla PHYTONADIONE phytonadione INJECTABLE;INJECTION 212424-001 Apr 22, 2022 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline PHYTONADIONE phytonadione INJECTABLE;INJECTION 084060-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cipla PHYTONADIONE phytonadione INJECTABLE;INJECTION 214596-002 Apr 22, 2022 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Lifesciences PHYTONADIONE phytonadione TABLET;ORAL 210189-001 Feb 20, 2019 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Intl Medication PHYTONADIONE phytonadione INJECTABLE;INJECTION 083722-001 Approved Prior to Jan 1, 1982 BP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cipla PHYTONADIONE phytonadione INJECTABLE;INJECTION 214596-001 Apr 22, 2022 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.